血浆纤维蛋白原与冠状动脉粥样硬化性心脏病(2)
 |
| 第1页 |
参见附件。
[8] 张薇,董平栓.纤维蛋白原与冠心病的相关性.医学综述,2007,9(17):1320.
[9] Temelkova Kurktschiev T,Koehler C,Henkel E,et al.Leukocyte count and fibrinogen are associated with carotid and femoral intima media thicknessin a risk population for diabetes.Cardiovasc.Res,2002,56(2):277:283.
[10] Humphries SE,Luong LA,Montgomery HE,et al.Gene environment interaction in the determination of levels of plasma fibrinogen.Thromb Haemostasis,1999,82(2): 818-825.
[11] Kannel WB.Fibrinogen and risk of cardiovascular disease.J Am Med Assoc,1987,258,1183.
[12] K robot-k.Determinant of plasma fibrinogen:relation to body weight,waist-to-hip ratio,smoking,alcohol,age and sex,results from thesecond MONICA Augalburg Survey.Arterionclerosis and Thrombosis,1992,12:780.
[13] 马惠莉,冯军,陈纪林,陈在嘉.纤维蛋白原与冠心病.心血管病学进展,2002,23(6):327.
[14] Verschuur M,Bekkers M,Van Erck MG,et al.Influence of plasmatrigly ceride and plasma cholesterol levels on the clearrance rate of fibrinogen.Ann N Y Acad Sci,2001,936:639-642.
[15] Sharp DS,Abbott RD,Burchfiel CM,et al.Plasma fibrinogen and coronary heart disease in elderly Japanese-American men.Arterioscler Thromb Vasc Biol,1996,16:622-268.
您现在查看是摘要介绍页，详见PDF附件。